These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Surgical care of patients with hereditary disorders of blood coagulation. Shulman NR Mod Treat; 1968 Jan; 5(1):61-83. PubMed ID: 4870180 [No Abstract] [Full Text] [Related]
3. The chemistry of blood coagulation. Baugh RF; Hougie C Clin Haematol; 1979 Feb; 8(1):3-30. PubMed ID: 367664 [No Abstract] [Full Text] [Related]
4. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors. Lämmle B; Griffin JH Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of an automatic clot-sensing instrument : Coag A Pet 200 (author's transl)]. Houbouyan L; Roussi J; Goguel A Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):199-208. PubMed ID: 704336 [TBL] [Abstract][Full Text] [Related]
6. [The physiology of blood platelets]. Lüscher EF Schweiz Med Wochenschr; 1968 Oct; 98(42):1629-35. PubMed ID: 5698340 [No Abstract] [Full Text] [Related]
7. Therapeutic materials used in the treatment of coagulation defects. Smith JK; Bidwell E Clin Haematol; 1979 Feb; 8(1):183-206. PubMed ID: 367662 [No Abstract] [Full Text] [Related]
8. Theory of blood coagulation in disseminated intravascular coagulation (D. I. C.). Murano G Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):5-19. PubMed ID: 4114585 [No Abstract] [Full Text] [Related]
9. Inhibitor of human blood coagulation elicited by thrombin. Marciniak E J Lab Clin Med; 1972 Jun; 79(6):924-34. PubMed ID: 5025460 [No Abstract] [Full Text] [Related]
12. Testing for potential thrombogenicity of prothrombin complex concentrates. Snape TJ Dev Biol Stand; 1979; 44():199-204. PubMed ID: 544295 [TBL] [Abstract][Full Text] [Related]
13. Characterization of procoagulants produced in cell cultures by tests of coagulation. Zacharski LR; McIntyre OR Thromb Diath Haemorrh; 1971 Dec; 26(3):493-502. PubMed ID: 5144962 [No Abstract] [Full Text] [Related]
14. [Thrombogenicity of a new prothrombin complex concentrate]. Klöcking HP; Klessen C; Jablonowski C; Meerbach W; Dornheim G Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):645-61. PubMed ID: 6083940 [TBL] [Abstract][Full Text] [Related]
15. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety. Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288 [TBL] [Abstract][Full Text] [Related]
16. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies. Buchanan GR; Kevy SV Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319 [TBL] [Abstract][Full Text] [Related]
17. The normal coagulation mechanism. Bennett B; Ratnoff OD Med Clin North Am; 1972 Jan; 56(1):95-104. PubMed ID: 4550195 [No Abstract] [Full Text] [Related]